Bryan Stuart files SEC Form 4 disclosures for Fulcrum Therapeutics, Inc.. They have made 1 open-market trade across 1 company since 2021, most recently 2021-08-11.
CIK 0001619846
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FULC | 32,000 | $117K |
Shares reported on the most recent Form 4, priced at the 2021-08-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FULC | SELL | 2021-08-10 | 2021-08-12 | $20.42 | $1.2M | +22.0% | +22.0% | -11.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.